Skip to main content

Peer Review reports

From: Real-world data analysis of immune checkpoint inhibitors in stage III-IV adenocarcinoma and squamous cell carcinoma

Original Submission
29 Oct 2021 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
31 Dec 2021 Reviewed Reviewer Report
8 May 2022 Reviewed Reviewer Report
15 May 2022 Reviewed Reviewer Report
29 May 2022 Author responded Author comments - Yu Li
Resubmission - Version 4
29 May 2022 Submitted Manuscript version 4
2 Jun 2022 Reviewed Reviewer Report
6 Jun 2022 Reviewed Reviewer Report
12 Jun 2022 Reviewed Reviewer Report
21 Jun 2022 Author responded Author comments - Yu Li
Resubmission - Version 5
21 Jun 2022 Submitted Manuscript version 5
Publishing
23 Jun 2022 Editorially accepted
13 Jul 2022 Article published 10.1186/s12885-022-09843-3

You can find further information about peer review here.

Back to article page